Menu Search
Equities

Prim SA

PRM:MCE

Prim SA

Actions
  • Price (EUR)10.00
  • Today's Change-0.10 / -0.99%
  • Shares traded3.05k
  • 1 Year change-5.21%
  • Beta0.4836
Data delayed at least 15 minutes, as of Nov 22 2024 15:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Prim SA grew revenues 9.77% from 197.25m to 216.51m while net income improved 51.02% from 8.39m to 12.67m.
Gross margin38.28%
Net profit margin5.02%
Operating margin6.44%
Return on assets5.73%
Return on equity9.14%
Return on investment8.34%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Prim SA fell by 4.44m. Cash Flow from Financing totalled 30.37m or 14.03% of revenues. In addition the company used 31.25m for operations while cash used for investing totalled 3.67m.
Cash flow per share1.31
Price/Cash flow per share7.58
Book value per share7.46
Tangible book value per share6.12
More ▼

Balance sheet in EURView more

Prim SA has a Debt to Total Capital ratio of 13.10%, a higher figure than the previous year's 9.69%.
Current ratio2.23
Quick ratio1.13
Total debt/total equity0.1507
Total debt/total capital0.131
More ▼

Growth rates in EUR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 21.84% and 51.46%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
Div yield(5 year avg)3.44%
Div growth rate (5 year)-5.01%
Payout ratio (TTM)50.16%
EPS growth(5 years)-1.78
EPS (TTM) vs
TTM 1 year ago		19.12
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.